|
The 2010 conference programme will not be available online until November 2009 - below is the 2009 conference programme for your information.
| Thursday, 29 January 2009 |
| |
|
| Emerging Issues in Clinical Chemistry |
| |
|
| 10:00 |
POCT – regional experience & recommendations
Dr. Gurdeep Dhatt, Senior Consultant, Clinical Biochemistry, Chair, Department of Laboratory Medicine, Tawam Hospital in affiliation with Johns Hopkins Medicine, Al Ain, UAE |
| |
|
| 10:30 |
The Clinical Chemistry Laboratory Perspective of Molecular Diagnostics
Prof. N. Kalsheker, Professor of Clinical Chemistry & Co-Director of Institute of Genetics, School of Molecular Medical Sciences, The University of Nottingham, Queens Medical Centre, Nottingham, UK |
| |
|
| 11:00 |
Coffee break |
| |
|
| 11:30 |
User Guidelines to eGFR, Cystatin C and Creatinine for Improved Renal Function
Prof. Joris Delanghe, Dept of Clinical Chemistry, Ghent University Hospital, Belgium |
| |
|
| 12:00 |
Seeing Through ‘Marker Jungle’ for Risk Stratification and Therapy
Dr. Paul Collinson, Consultant Chemical Pathologist, St George's Hospital, UK
|
| |
|
| 12:30 |
Development of Target Based Assay Systems for Pancreatic Cancers
Dr. Satish Chandra Nair, Tawam Hospital, Al Ain, UAE |
| |
|
| 13:00 |
Lunch break |
| |
|
| Clinical Chemistry: Trends for Future |
| |
|
| 14:30 |
Newborn Screening for Congenital Adrenal Hyperplasia Using Liquid Chromatography Tandem Mass Spectrometry
Dr. Don Cooper, Clinical Research Manager, Clinical Operations Group, Waters Corporation, Manchester, UK |
| |
|
| 15:00 |
The Role of Vitamin D, Beyond Calcium Homeostasis
Dr. Saad Baher El Badawi, Laboratory Director, Erfan & Bagedo Hospitals, Jeddah. Saudi Arabia |
| |
|
| 15:30 |
Coffee break |
| |
|
| 16:00 |
Biochemical markers for brain injury & disease - are any ready for clinical use?
Dr. Roy Sherwood, Consultant Clinical Biochemist, Department of Clinical Biochemistry, King's College Hospital Medical School, UK |
| |
|
| 16:30 |
The Analysis of 25-Hydroxyvitamin D in Serum Using UPLC/MS/MS
Dr. Don Cooper, Clinical Research Manager, Clinical Operations Group, Waters Corporation, Manchester, UK |
| |
|
| 17:00 |
Close |
| |
|
| |
|
| |
|
| INVITED SPEAKER FACULTY: |
|
Dr. Paul Collinson, Consultant Chemical Pathologist, St George's Hospital, UK
Dr. Don Cooper, Clinical Research Manager, Clinical Operations Group, Waters Corporation, Manchester, UK
Dr. Gurdeep Dhatt, Senior Consultant, Clinical Biochemistry, Chair, Department of Laboratory Medicine, Tawam Hospital in affiliation with Johns Hopkins Medicine, Al Ain, UAE
Prof Joris Delanghe, Dept of Clinical Chemistry, Ghent University Hospital, Belgium
Dr. Saad Baher El Badawi, Laboratory Director, Erfan & Bagedo Hospitals, Jeddah, KSA
Prof. N. Kalsheker, Professor of Clinical Chemistry & Co-Director of Institute of Genetics, School of Molecular Medical Sciences, The University of Nottingham, Queens Medical Centre, Nottingham, UK
Dr. Satish Chandra Nair, Tawam Hospital, Al Ain, UAE
Dr. Roy Sherwood, Consultant Clinical Biochemist, Department of Clinical Biochemistry, King's College Hospital Medical School, UK
|
|